Kasia Averall

Kasia Averall joined Cell and Gene Therapy Catapult in November 2016, tasked with establishing the pharmaceutical quality system for the new multiproduct, multi-collaborator ATMP manufacturing center in Stevenage, UK. The facility was successfully licensed by the UK MHRA in August 2018, and Kasia now leads the quality assurance team supporting a variety of cell and gene therapy manufacturers. Before joining Cell and Gene Therapy Catapult, Kasia worked in both quality assurance and regulatory affairs over a range of dosage forms. She has a degree in natural sciences (biological) from the University of Cambridge.